293 related articles for article (PubMed ID: 25089127)
21. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
[TBL] [Abstract][Full Text] [Related]
22. A 2017 SURVEY OF THE CLINICAL PRACTICE PATTERNS IN THE MANAGEMENT OF RELAPSING GRAVES DISEASE.
Koren S; Shteinshnaider M; Or K; Cantrell D; Benbassat CA; Koren R
Endocr Pract; 2019 Jan; 25(1):55-61. PubMed ID: 30383500
[TBL] [Abstract][Full Text] [Related]
23. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
24. Controversies in the pharmacological treatment of Graves' disease in children.
De Luca F; Valenzise M
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
[TBL] [Abstract][Full Text] [Related]
25. Antithyroid drugs during breastfeeding.
Hudzik B; Zubelewicz-Szkodzinska B
Clin Endocrinol (Oxf); 2016 Dec; 85(6):827-830. PubMed ID: 27561657
[TBL] [Abstract][Full Text] [Related]
26. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
27. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the medical treatment of Graves' disease (GD)].
Peixoto MC; Coeli CM; Vaisman M
Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):410-9. PubMed ID: 16543996
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease.
Cury AN; Meira VT; Monte O; Marone M; Scalissi NM; Kochi C; Calliari LE; Longui CA
Endocr Connect; 2013 Mar; 2(1):32-7. PubMed ID: 23781316
[TBL] [Abstract][Full Text] [Related]
30. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
[No Abstract] [Full Text] [Related]
31. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
32. Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug.
Gheorghiu ML; Bors RG; Gheorghisan-Galateanu AA; Pop AL; Cretoiu D; Varlas VN
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442037
[TBL] [Abstract][Full Text] [Related]
33. [Childhood Graves' disease].
Sasaki N; Sato K
Nihon Rinsho; 2006 Dec; 64(12):2308-11. PubMed ID: 17154097
[TBL] [Abstract][Full Text] [Related]
34. Antithyroid drug therapy for Graves' hyperthyroidism: is long-term administration of a small maintenance dose necessary?
Tajiri J; Noguchi S; Morita M; Tamaru M; Murakami N
Endocrinol Jpn; 1991 Apr; 38(2):223-7. PubMed ID: 1684322
[TBL] [Abstract][Full Text] [Related]
35. Five cases of childhood-onset Graves' disease treated with either surgery or radio-iodine therapy.
Tomari K; Goto M; Shimada A; Yagi H; Nagashima Y; Hasegawa Y
Clin Pediatr Endocrinol; 2017; 26(4):265-269. PubMed ID: 29026276
[TBL] [Abstract][Full Text] [Related]
36. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies.
Gomez-Peralta F; Velasco-Martínez P; Abreu C; Cepeda M; Fernández-Puente M
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29340156
[TBL] [Abstract][Full Text] [Related]
37. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
38. Comparison Between the Treatment Modalities for Graves' Disease at King Abdulaziz Medical City, Jeddah.
Zarif HA; Alam SS; Baashar A; Alsharif A; Alhilabi M
Cureus; 2020 Jan; 12(1):e6730. PubMed ID: 32015936
[TBL] [Abstract][Full Text] [Related]
39. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Okamura K; Bandai S; Fujikawa M; Sato K; Kitazono T
Endocr J; 2020 Jul; 67(7):751-758. PubMed ID: 32238669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
